News
Benefits of Pradaxa® maintained in difficult to treat patients...
Published in the European Journal of Heart Failure1, results from a new sub-analysis of the RE-LY®* trial demonstrate important benefits of Pradaxa® (dabigatran etexilate) over...
News
Immune-boosting colorectal cancer drug shows promise
New data on an emerging treatment that aims to fight colorectal cancer by stimulating the immune system have been presented at the ESMO 15th World...
News
FDA takes action to protect consumers from dangerous medicines...
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 9,600 websites that...
News
Targeted viral therapy destroys breast cancer stem cells in...
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) has...
News
FDA obtains waiver from European Commission to facilitate export...
The U.S. Food and Drug Administration announced that the U.S. is now a "listed" countrydisclaimer icon with the European Commission (EC) so that U.S. companies...
News
Aspirin may fight cancer by slowing DNA damage
Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation,...
News
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement...
AstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.